| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |